Bexion Pharmaceuticals Unveils Upcoming Poster Presentations at ASCO 2026 Event Bexion Pharmaceuticals, Inc. plans to present critical findings on BXQ-350 at the ASCO Gastrointestinal Cancers Symposium in January 2026.

Bexion Pharmaceuticals Unveils Upcoming Poster Presentations at ASCO 2026 Event #United_States #San_Francisco #Bexion_Pharmaceuticals #BXQ-350 #ASCO_Symposium

Quest Diagnostics to Showcase Cutting-Edge Data on ctDNA MRD Testing at ASCO 2026 Quest Diagnostics will unveil significant new data regarding circulating tumor DNA MRD testing at the 2026 ASCO Gastrointestinal Cancers Symposium in San Francisco.

Quest Diagnostics to Showcase Cutting-Edge Data on ctDNA MRD Testing at ASCO 2026 #United_States #San_Francisco #Quest_Diagnostics #Haystack_MRD #ASCO_Symposium